INDICATIONS FOR PREVNAR 20®

Prevnar 20 is a vaccine approved for:

  • the prevention of invasive disease caused by 20 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) in individuals 6 weeks and older.
  • the prevention of otitis media (middle ear infection) caused by 7 of the 20 strains in individuals 6 weeks through 5 years.

What Is Invasive Pneumococcal Disease (IPD)?

IPD can potentially lead to serious illness for your baby

Invasive pneumococcal disease (in-vay-siv noo-mo-ca-cal disease), or IPD, is the name for a group of illnesses caused by pneumococcal bacteria. IPD can include:

Resource image

An infection of the lining around the brain and spinal cord called pneumococcal meningitis
(noo-mo-ca-cal men-in-ghi-tis)

Resource image

An infection of the blood called pneumococcal bacteremia
(noo-mo-ca-cal bak-tuh-ree-mee-uh)

IPD can potentially put your child’s life at risk in serious cases. Pneumococcal meningitis may lead to long-term effects including brain damage or even death.

Bacteria that cause IPD can enter your child’s body through the mouth, throat, or eyes.

Resource image

Bacteria that cause IPD can enter your child’s body through the mouth, throat, or eyes.

Resource image

IPD can spread through cough or close contact, and children under 2 years old are at increased risk

Among children, babies under 2 years old are at highest risk of developing IPD from pneumococcal bacterial infection.

Pneumococcal bacteria are spread by close contact through coughing or touching an object with bacteria on it.

You can reduce the risk for your baby by having them vaccinated with PREVNAR 20®—which helps provide protection against 20 strains of the bacteria that cause IPD.


Vaccines help protect babies

As a parent, you do everything you can to keep your baby safe. Vaccines help keep your baby safe by helping prevent disease.

Vaccines have helped make certain diseases that were once widespread—such as smallpox, polio, diphtheria, measles, mumps, and rubella—feel like a distant memory. But these childhood diseases will only stay controlled if most children are vaccinated.

Should an outbreak happen, babies who haven’t gotten all their vaccinations are at higher risk of getting a disease that, in serious cases, could lead to a hospital stay, disability, or even death.

Help protect your baby from the chance for possible serious effects from IPD. Talk to your baby’s doctor about PREVNAR 20.

Learn more about PREVNAR 20

INDICATIONS AND IMPORTANT SAFETY INFORMATION

INDICATIONS FOR PREVNAR 20®

Prevnar 20 is a vaccine approved for:

  • the prevention of invasive disease caused by 20 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) in individuals 6 weeks and older.
  • the prevention of otitis media (middle ear infection) caused by 7 of the 20 strains in individuals 6 weeks through 5 years.

IMPORTANT SAFETY INFORMATION FOR PREVNAR 20

  • Prevnar 20 should not be given to anyone who has had a severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid.
  • Individuals with weakened immune systems may have a lower immune response. Safety data are not available for these groups.
  • A temporary pause in breathing after getting the vaccine has been observed in some infants who were born prematurely. For premature infants, talk to your healthcare provider about the infant's medical status when deciding to get vaccinated with Prevnar 20.
  • In individuals 2, 4, 6, and 12 through 15 months of age vaccinated with a 4-dose schedule, the most common side effects reported at a rate of >10% were irritability, pain at the injection site, drowsiness, decreased appetite, injection site redness, injection site swelling, and fever.
  • In individuals 15 months through 17 years of age vaccinated with a single dose, the most common side effects reported at a rate of >10% were irritability, pain at the injection site, drowsiness, fatigue, muscle pain, decreased appetite, injection site swelling, injection site redness, headache, and fever.
  • Ask your healthcare provider about the risks and benefits of Prevnar 20.

Please click here for full Prescribing Information for PREVNAR 20®.

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.


This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

INDICATIONS AND IMPORTANT SAFETY INFORMATION

FIND OUT MORE

COLLAPSE

INDICATIONS FOR PREVNAR 20®

Prevnar 20 is a vaccine approved for:

  • the prevention of invasive disease caused by 20 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) in individuals 6 weeks and older.
  • the prevention of otitis media (middle ear infection) caused by 7 of the 20 strains in individuals 6 weeks through 5 years.

IMPORTANT SAFETY INFORMATION FOR PREVNAR 20

  • Prevnar 20 should not be given to anyone who has had a severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid.
  • Individuals with weakened immune systems may have a lower immune response. Safety data are not available for these groups.
  • A temporary pause in breathing after getting the vaccine has been observed in some infants who were born prematurely. For premature infants, talk to your healthcare provider about the infant's medical status when deciding to get vaccinated with Prevnar 20.
  • In individuals 2, 4, 6, and 12 through 15 months of age vaccinated with a 4-dose schedule, the most common side effects reported at a rate of >10% were irritability, pain at the injection site, drowsiness, decreased appetite, injection site redness, injection site swelling, and fever.
  • In individuals 15 months through 17 years of age vaccinated with a single dose, the most common side effects reported at a rate of >10% were irritability, pain at the injection site, drowsiness, fatigue, muscle pain, decreased appetite, injection site swelling, injection site redness, headache, and fever.
  • Ask your healthcare provider about the risks and benefits of Prevnar 20.

Please click here for full Prescribing Information for PREVNAR 20®.

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.


This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.